circLMTK2 knockdown attenuated GEM-resistant PC cells by regulating PAK1 via miR-485-5p.
CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1.